March 25, 2011
Some Good News About a Very Bad Cancer
Mitch Leslie, Science Now
Pancreatic cancer is relentless and typically kills patients within a few months. Now scientists report that a treatment that fires up certain immune cells extends the lives of pancreatic cancer patients by more than 30%. Although the recipients survived for only about an extra 2 months, cancer researchers are enthusiastic about the results.
TAGGED: immune system, antibodies, experimental drug, cancer, pancreatic cancer